David B. Smith

The Impact of SFAS No. 131 Business Segment Data on the Market's Ability to Anticipate Future Earnings

Michael Ettredge, Soo Young Kwon, David B. Smith et al. · The Accounting Review · 2005 · 274 citations

Business, Accountancy, Accounting +17

The Novel Nucleoside Analog R1479 (4′-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture

Klaus Klumpp, Vincent Lévêque, Sophie Le Pogam et al. · Journal of Biological Chemistry · 2005 · 215 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +15

Busyness, Expertise, and Financial Reporting Quality of Audit Committee Chairs and Financial Experts

Paul Tanyi, David B. Smith · Auditing A Journal of Practice & Theory · 2014 · 195 citations

Business, Accountancy, Accounting +16

Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection

Guangyi Wang, Jérôme Deval, Jin Tae Hong et al. · Journal of Medicinal Chemistry · 2015 · 138 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Characterization of the Metabolic Activation of Hepatitis C Virus Nucleoside Inhibitor β-d-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and Identification of a Novel Active 5′-Triphosphate Species

Han Ma, Wen-Rong Jiang, Nicole L. Robledo et al. · Journal of Biological Chemistry · 2007 · 114 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17